X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (260564) 260564
Book Chapter (682) 682
Dissertation (541) 541
Book / eBook (253) 253
Reference (223) 223
Conference Proceeding (218) 218
Magazine Article (203) 203
Newsletter (173) 173
Publication (170) 170
Government Document (137) 137
Web Resource (90) 90
Newspaper Article (49) 49
Streaming Video (13) 13
Journal / eJournal (12) 12
Book Review (11) 11
Transcript (4) 4
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (172014) 172014
animals (128311) 128311
mice (69126) 69126
male (64319) 64319
female (63682) 63682
oncology (55375) 55375
biochemistry & molecular biology (45120) 45120
apoptosis (44067) 44067
expression (43426) 43426
cell biology (43404) 43404
cancer (35876) 35876
phosphorylation (33610) 33610
signal transduction (33525) 33525
cell line, tumor (33228) 33228
rats (31925) 31925
proto-oncogene proteins c-akt - metabolism (29276) 29276
middle aged (28379) 28379
mutation (27399) 27399
proto-oncogene proteins - genetics (26960) 26960
activation (26477) 26477
proto-oncogene proteins - metabolism (26144) 26144
adult (25157) 25157
cell line (23996) 23996
oncogenes (23932) 23932
cells, cultured (23162) 23162
gene expression (22977) 22977
proteins (22760) 22760
aged (21895) 21895
apoptosis - drug effects (21491) 21491
immunohistochemistry (21452) 21452
molecular sequence data (20837) 20837
research (20522) 20522
proto-oncogene proteins c-bcl-2 - metabolism (17751) 17751
base sequence (17620) 17620
genetic aspects (16817) 16817
gene (16345) 16345
signal transduction - drug effects (16200) 16200
tumors (15926) 15926
cells (15918) 15918
transfection (15918) 15918
protein (15637) 15637
gene expression regulation, neoplastic (15311) 15311
analysis (15250) 15250
cell proliferation (15040) 15040
tumor cells, cultured (14985) 14985
research article (14506) 14506
prognosis (14053) 14053
phosphatidylinositol 3-kinases - metabolism (13915) 13915
genetics & heredity (13632) 13632
neurosciences (13578) 13578
blotting, western (13548) 13548
hematology (13276) 13276
amino acid sequence (13188) 13188
oncogene (13015) 13015
pathology (12306) 12306
gene-expression (12247) 12247
growth (12192) 12192
mice, inbred c57bl (12106) 12106
multidisciplinary sciences (12092) 12092
genes (11748) 11748
protein binding (11281) 11281
gene expression regulation (11181) 11181
cell proliferation - drug effects (11106) 11106
kinases (11089) 11089
rats, sprague-dawley (11014) 11014
rna, messenger - metabolism (10804) 10804
physiological aspects (10764) 10764
proliferation (10720) 10720
time factors (10695) 10695
antineoplastic agents - pharmacology (10579) 10579
cell cycle (10398) 10398
rna, messenger - genetics (10387) 10387
inhibition (10302) 10302
health aspects (9962) 9962
differentiation (9939) 9939
dna-binding proteins - genetics (9922) 9922
survival (9853) 9853
p53 (9745) 9745
dna-binding proteins - metabolism (9713) 9713
reverse transcriptase polymerase chain reaction (9628) 9628
medicine, research & experimental (9616) 9616
immunology (9517) 9517
aged, 80 and over (9393) 9393
down-regulation (9357) 9357
pharmacology & pharmacy (9203) 9203
proto-oncogene proteins c-bcl-2 - genetics (9163) 9163
signal transduction - physiology (9138) 9138
transcription, genetic (9092) 9092
disease models, animal (8996) 8996
transcription factors - metabolism (8996) 8996
metastasis (8974) 8974
akt (8973) 8973
polymerase chain reaction (8932) 8932
in-vivo (8840) 8840
transcription factors (8828) 8828
transcription factors - genetics (8809) 8809
tumor suppressor protein p53 - metabolism (8745) 8745
pathway (8719) 8719
mice, knockout (8617) 8617
bcl-2 (8549) 8549
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (189) 189
Online Resources - Online (90) 90
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
UofT at Mississauga - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
UTL at Downsview - May be requested (7) 7
UofT at Scarborough - Stacks (4) 4
Gerstein Science - Periodical Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Gerstein Science - Bindery (2) 2
Gerstein Science - Circulation Desk (2) 2
Robarts - Stacks (2) 2
St. Michael's Hospital - Circulation Desk (2) 2
St. Michael's Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Media Commons - Audio Visual (1) 1
Providence Healthcare - Withdrawn (1) 1
Scarborough Hospital - Online (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (257560) 257560
Chinese (4574) 4574
Japanese (2468) 2468
French (1195) 1195
German (731) 731
Russian (710) 710
Spanish (456) 456
Portuguese (285) 285
Polish (210) 210
Italian (103) 103
Korean (99) 99
Hungarian (86) 86
Czech (80) 80
Romanian (50) 50
Norwegian (44) 44
Dutch (41) 41
Ukrainian (24) 24
Turkish (21) 21
Swedish (19) 19
Danish (18) 18
Croatian (17) 17
Finnish (16) 16
Serbian (16) 16
Slovak (16) 16
Persian (11) 11
Bulgarian (9) 9
Hebrew (9) 9
Arabic (3) 3
Latin (3) 3
Welsh (3) 3
Slovenian (2) 2
Bosnian (1) 1
Lithuanian (1) 1
Nauru (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncogene, ISSN 0950-9232, 1987
Journal
British journal of clinical pharmacology, ISSN 0306-5251, 2016, Volume 82, Issue 4, pp. 943 - 956
Journal Article
1994, 1, ISBN 0849345731, 310
This book introduces and analyzes the crucial role of AP-1 in cell growth, proliferation, differentiation, and apoptosis. AP-1 is the endpoint of several... 
Jun oncogenes | Fos oncogenes | Transcription factors | Biochemistry
Book
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2009, Volume 101, Issue 19, pp. 1308 - 1324
The monoclonal antibodies panitumumab and cetuximab that target the epidermal growth factor receptor (EGFR) have expanded the range of treatment options for... 
CELL LUNG-CANCER | PHASE-III TRIAL | TYROSINE KINASE INHIBITORS | COLON-CANCER | KRAS MUTATIONS | K-RAS MUTATIONS | PROGRESSION-FREE-SURVIVAL | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | IN-SITU HYBRIDIZATION | GENE COPY NUMBER | PTEN Phosphohydrolase - drug effects | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Antibodies, Monoclonal - therapeutic use | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Colorectal Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - drug effects | Biomarkers, Tumor - metabolism | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Cetuximab | Odds Ratio | PTEN Phosphohydrolase - genetics | Proto-Oncogene Proteins - drug effects | Antibodies, Monoclonal - pharmacology | Proto-Oncogene Proteins - genetics | Randomized Controlled Trials as Topic | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins p21(ras) - drug effects | Animals | Class I Phosphatidylinositol 3-Kinases | Mutation - drug effects | Proto-Oncogene Proteins B-raf - drug effects | Proto-Oncogene Proteins B-raf - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Colorectal Neoplasms - pathology | Neoplasm Staging | Research Design | Usage | Care and treatment | Prognosis | Gene mutations | Colorectal cancer | Monoclonal antibodies | Development and progression | Genetic aspects | Research | Biological markers | Health aspects | Review
Journal Article
Nature (London), ISSN 1476-4687, 2010, Volume 468, Issue 7326, pp. 968 - 972
Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50-70% of malignant melanomas(1). Pre-clinical studies have... 
TRANSFORMATION | CELLS | ACTIVATION | TUMOR PROGRESSION | GENE | SIGNALING PATHWAY | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | BRAF | MUTATIONS | CANCER | Allosteric Regulation | Humans | Gene Expression Regulation, Neoplastic | Melanoma - enzymology | Gene Expression Profiling | MAP Kinase Signaling System | Mitogen-Activated Protein Kinase Kinases - metabolism | Melanoma - genetics | Indoles - pharmacology | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Gene Library | Proto-Oncogene Proteins c-raf - genetics | MAP Kinase Kinase Kinases - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - genetics | Clinical Trials as Topic | MAP Kinase Kinase Kinases - metabolism | Enzyme Activation - drug effects | Open Reading Frames - genetics | Sulfonamides - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Drug Resistance, Neoplasm - genetics | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Indoles - therapeutic use | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Protein research | Research | Properties | Protein kinases | Cancer cells | Cell lines | Biochemistry | Mutation | Kinases | Genes | Cancer
Journal Article
Molecular cell, ISSN 1097-2765, 2015, Volume 58, Issue 6, pp. 1028 - 1039
The bromodomain and extraterminal (BET) protein BRD4 is a validated drug target in leukemia, yet its regulatory function in this disease is not well... 
SELECTIVE-INHIBITION | RECRUITMENT | C/EBP-ALPHA | CREB-BINDING PROTEIN | CHROMATIN | ACETYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | C-MYC | P-TEFB | BRD4 | CELL BIOLOGY | Transcriptional Regulator ERG | NIH 3T3 Cells | Oncogene Proteins - genetics | Humans | Leukemia, Myeloid - genetics | Proto-Oncogene Proteins c-myb - genetics | Gene Expression Profiling | Leukemia, Myeloid - pathology | RNA Interference | Proto-Oncogene Protein c-fli-1 - metabolism | Protein Binding - drug effects | Trans-Activators - genetics | Nuclear Proteins - genetics | Proto-Oncogene Proteins - metabolism | Acute Disease | Proto-Oncogene Protein c-fli-1 - genetics | CCAAT-Enhancer-Binding Protein-beta - genetics | Oncogene Proteins - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Transcription Factors - antagonists & inhibitors | Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | CCAAT-Enhancer-Binding Protein-beta - metabolism | Proto-Oncogene Proteins c-myb - metabolism | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Acetylation - drug effects | Animals | Hematopoietic System - metabolism | Leukemia, Myeloid - metabolism | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | Trans-Activators - metabolism | Mice | Histones - metabolism | DNA binding proteins | Medicine, Experimental | Medical research | Chromatin | Lysine
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 86, Issue 3, pp. 324 - 328
Highlights • We investigated the presence of mutations in a panel of 6 genes in 113 SCLCs. • We could identify only 7 mutations, 2 in EGFR and 5 in c-MET gene.... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | SCLC | PDGFRa | Gene mutations | c-KIT | c-MET | BRAF | KRAS | EGFR | C-MET | C-KIT | GEFITINIB | EGFR MUTATION | TRIAL | ONCOLOGY | RESPIRATORY SYSTEM | FACTOR RECEPTOR MUTATIONS | JAPANESE | CARCINOMA | EXPRESSION | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins c-met - biosynthesis | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Molecular Targeted Therapy | Proto-Oncogene Proteins - biosynthesis | Proto-Oncogene Proteins c-kit - biosynthesis | Receptor, Platelet-Derived Growth Factor beta - genetics | Small Cell Lung Carcinoma - drug therapy | ras Proteins - biosynthesis | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Receptor, Epidermal Growth Factor - biosynthesis | Proto-Oncogene Proteins - genetics | Small Cell Lung Carcinoma - genetics | Proto-Oncogene Proteins c-met - genetics | Disease-Free Survival | Small Cell Lung Carcinoma - pathology | Proto-Oncogene Proteins B-raf - biosynthesis | Proto-Oncogene Proteins B-raf - genetics | Aged | Mutation | Receptor, Platelet-Derived Growth Factor beta - biosynthesis | Lung cancer | Genes | Genetic research | Genetic aspects | Diagnosis | Cervical cancer | Cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 18, pp. 1733 - 1747
Journal Article
Molecular cell, ISSN 1097-2765, 2016, Volume 64, Issue 3, pp. 493 - 506
MYCN amplification in human cancers predicts poor prognosis and resistance to therapy. However, pharmacological strategies that directly target N-Myc, the... 
BI6727 | targeted therapy | ubiquitination | Myc | PLK1 | neuroblastoma | Fbw7 | small cell lung carcinoma | ABT199 | TARGETED THERAPY | INHIBITOR VOLASERTIB | BIOCHEMISTRY & MOLECULAR BIOLOGY | N-MYC | C-MYC | F-BOX PROTEINS | AMPLIFIED NEUROBLASTOMA | AURORA KINASE | FBW7 UBIQUITIN LIGASE | CANCER-THERAPY | HUMAN NEUROBLASTOMA | CELL BIOLOGY | RNA, Small Interfering - genetics | Humans | Neuroblastoma - mortality | N-Myc Proto-Oncogene Protein - antagonists & inhibitors | Transcription, Genetic | Neurons - metabolism | Brain Neoplasms - mortality | Protein-Serine-Threonine Kinases - metabolism | Signal Transduction | Cell Cycle Proteins - metabolism | Ubiquitin-Protein Ligases - metabolism | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Sulfonamides - pharmacology | Drug Synergism | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Feedback, Physiological | Mice, Nude | Survival Analysis | Cell Line, Tumor | Ubiquitin-Protein Ligases - genetics | F-Box Proteins - genetics | RNA, Small Interfering - metabolism | F-Box-WD Repeat-Containing Protein 7 | Neurons - pathology | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | N-Myc Proto-Oncogene Protein - genetics | Cell Cycle Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Antineoplastic Agents - pharmacology | Neurons - drug effects | Neuroblastoma - pathology | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Pteridines - pharmacology | F-Box Proteins - metabolism | Neuroblastoma - genetics | Protein-Serine-Threonine Kinases - genetics | Proto-Oncogene Proteins - genetics | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | N-Myc Proto-Oncogene Protein - metabolism | Neuroblastoma - drug therapy | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - genetics | Ubiquitin | Polo | Ligases | Lung cancer | Therapeutics | Homeopathy | Materia medica and therapeutics | Cancer
Journal Article